Richard Lee, Ph.D.
Senior Director, Preclinical Pharmacology and Translational Medicine
Richard Lee is the senior director, preclinical pharmacology and translational medicine at Verve Therapeutics. He has over 14 years’ experience in cardiovascular and metabolic preclinical pharmacology. Prior to joining Verve, he worked as the scientific metabolic lead at Ionis Pharmaceuticals, where he led the preclinical pharmacology efforts for vupanorsen, an ANGPTL3 antisense oligonucleotide in clinical trials for mixed dyslipidemia. Dr. Lee received his B.S. in biology from Western University and his Ph.D. in Cellular and Molecular Pathobiology from Wake Forest University.